Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:849217-68-1,CAS 849217-68-1,CAS Number 849217-68-1
Conbott Pharmtech Co.,Ltd. 849217-68-1,CAS 849217-68-1,CAS Number 849217-68-1
Home > Products > Inhibitors > VEGFR Inhibitors > VEGFR Inhibitor Cabozantinib CAS 849217-68-1
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

VEGFR Inhibitor Cabozantinib CAS 849217-68-1

Share to:  
    Payment Type: L/C,T/T
    Min. Order: 1 Gram

Basic Info

Model No.849217-68-1

BrandCONBOTTPHARM

Additional Info

PackagingAS Required

ProductivityCustomized

TransportationOcean,Air

Place of OriginCHINA

Supply AbilityCommercial

CertificateDOCUMENT SUPPORT

Payment TypeL/C,T/T

Product Description

Cabozantinib as known as CABXL-184 CAS number 849217-68-1 which Is a novel multi-target tyrosine kinase inhibitor, as a regulator of MET, vascular endothelial growth factor receptor 2 (VEGFR2) and RET tyrosine Kinase Inhibitors that can block the development and progression of tumor cells and are clinically used in the treatment of patients with progressive, metastatic thyroid medullary carcinoma (MTC). In vitro biochemical and cytological analysis showed that Cabozantinib can inhibit a variety of kinase activity and play an anti-tumor effect, kill tumor cells, reduce metastasis and inhibit tumor angiogenesis. patients treated with Cabozantinib,the incidence of gastrointestinal perforation and fistula formation was 3% and 1% respectively, For patients with perforation or fistula formation, Cabozantinib CAS 849217-68-1 should be terminated immediately. A large number of clinical experimental data show that the efficacy of Cabozantinib is significantly better than everolimus.

Thera. Category: Anti cancer

Cas No.: 849217-68-1

Synonym: XL-184 free base (Cabozantinib);BMS907351;N-(4-((6,7-DiMethoxyquino;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;Cabozantinib;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;XL184;Cabozantinib(XL184);

849217-68-1

Molecular Formula:C28H24FN3O5

Molecular Weight502                  

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Synthesis Pharmaceutical Intermediates


Product Categories : Inhibitors > VEGFR Inhibitors

Product Images
  • VEGFR Inhibitor Cabozantinib CAS 849217-68-1
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?